Raymond Scott Turner, MD| Neurology | MedStar Health
About me
Raymond Scott Turner, MD, PhD, is professor of neurology and director of the Memory Disorders program at MedStar Georgetown University Medical Center. Before his recruitment to Georgetown in 2008, he was chief of the neurology service at the VA Ann Arbor Healthcare System and associate professor and associate chair in the Department of Neurology, University of Michigan. Dr. Turner earned his medical degree and a PhD in pharmacology from Emory University, Atlanta, and completed his internship, residency and fellowship at the University of Pennsylvania, Philadelphia. He is board certified in psychiatry and neurology.
Dr. Turner has received numerous prestigious awards, including a fellowship from the Howard Hughes Medical Institute and a Paul Beeson Scholarship. He lectures widely, serves as a reviewer for granting agencies and biomedical journals, and has published more than 70 peer-reviewed papers, editorials and book chapters.
At the MedStar Georgetown Memory Disorders Program, Dr. Turner and his team offer diagnostic services as well as clinical care for older individuals with cognitive disorders. The program also offers a range of research opportunities designed to discover more effective prevention and treatment strategies. To do this, the program partners with healthy older volunteers at risk, as well as individuals with mild cognitive impairment or dementia due to Alzheimer's disease. The program's research is increasingly focused on individuals in the earliest disease stage -- when new treatments may be most effective. Dr. Turner encourages anyone interested in learning more to visit the program website: memory.georgetown.edu
Dr. Turner's Philosophy of Care:
Alzheimer's disease and other progressive dementias of aging are devastating for an individual and his or her family. It is important to seek medical evaluation early if you suspect memory problems are developing. A reversible cause of memory loss may be uncovered, and proven treatments with modest benefits for individuals with mild cognitive impairment or dementia due to Alzheimer's disease are available now. Our team of clinicians have the experience and expertise to provide compassionate and knowledgeable care based on the latest research. We also welcome volunteers and their families to learn about research opportunities and consider participating in a study. This is the only way we will make progress on the war against Alzheimer's disease.
Clinical areas of focus
- Alzheimer's Disease
- Aphasia Therapy
- Cervical Epidural Steroid Injection
- Chronic Headache Treatment
- Cognitive Function Disorders
- Confusion
- Dementia
- Depression
- Dizziness And Lightheadedness
- Facial Nerve Stimulation
- Huntington's Disease Management
- Memory Disorder
- Memory Therapy
- Neurocognitive Disorders
- Neurodegenerative Disease Treatment
- Neuropathy
- Pulsatile Tinnitus Treatment
- Sports Concussion
- Tremor
- Vascular Dementia
Conditions and procedures
Conditions I treat
- Abnormal Body Structure Imaging
- Abnormal Movements
- Agnosia
- Alzheimer's Disease
- Amnesia
- Amyotrophic Lateral Sclerosis
- Amyotrophic Lateral Sclerosis (ALS)
- Anxiety
- Aphasia
- Apraxia
- Autonomic Nervous System Disorder
- Bell's Palsy
- Benign Essential Tremor
- Bipolar Disorder
- Blurred Vision
- Brain Aneurysm
- Brain Disorders
- Brain Tumor
- Carotid Stenosis
- Cerebrovascular Diseases
- Cocaine Related Disorders
- Cognitive Function Disorders
- Cognitive Slowing
- Confusion
- Convulsions
- Creutzfeldt
- Degenerative Diseases Of Nervous System
- Dementia
- Depression
- Disorders Of Autonomic Nervous System
- Disorientation
- Dizziness And Lightheadedness
- Dystonia
- Encephalitis
- Epilepsy
- Executive Function Disorder
- Facial Nerve Palsy
- Facial Pain
- Fatal Insomnia
- Gait And Balance Problems
- General Sensations And Perceptions
- Gerstmann
- Headache
- Hemiplegia
- Huntington's Disease
- Hydrocephalus
- Malignant Neoplasm Of Meninges
- Memory Disorder
- Memory Loss
- Migraine
- Mild Cognitive Impairment
- Mood Disorders
- Multiple Sclerosis
- Neuralgia
- Neurocognitive Disorders
- Neuropathy
- Nontraumatic Subarachnoid Hemorrhage
- Numbness
- Ocular Myasthenia Gravis
- Parkinson's Disease
- Personal History Of Diseases And Conditions
- Prion Diseases
- Pulmonary Vasculitis
- Restless Leg Syndrome
- Seizure Disorders
- Sensory Neuropathy
- Skin Numbness Or Tingling
- Speech Disturbances
- Sports Concussion
- Subcortical Infarction
- Syncope
- Transient Ischemic Attack (TIA)
- Traumatic Brain Injury
- Tremor
- Trigeminal Neuralgia
- Vascular Dementia
- Vertigo
- Vision Disturbances
Procedures I perform
- Adrenal Hormone Level Testing
- Angiogram
- Aphasia Therapy
- Biofeedback
- Blood Gas Analysis
- Brain Angiogram
- Brain Biopsy
- Brain Imaging
- Brain Perfusion Scan
- Brainstem Auditory Evoked Potentials
- Cervical Epidural Steroid Injection
- Chronic Headache Treatment
- Cognitive Behavioral Therapy
- Cognitive Stimulation Therapy
- Computed Tomography
- Computerized Tomography (CT) Scan
- Deep Brain Stimulation
- Electroencephalogram
- Electromyography
- Epilepsy Surgery
- Facial Nerve Stimulation
- Fatigue Management
- Fine Motor Skills Evaluation
- Flash Electroretinography
- Functional Mri
- Gait And Balance Evaluation
- Geriatric Health Screening
- Huntington's Disease Management
- Intravenous Immunoglobulin
- Lewy Body Dementia Treatment
- Lumbar Puncture
- Magnetic Resonance Imaging (MRI)
- Median Nerve Conduction Studies
- Memory Disorder Treatment
- Memory Therapy
- Mep (MOTOR EVOKED POTENTIALS)
- Muscle Biopsy
- Myasthenia Gravis Treatment
- Nerve Block
- Nerve Stimulation
- Neurodegenerative Disease Treatment
- Neuromuscular Reeducation For Muscle Control
- Neuromuscular Rehabilitation
- Neuromuscular Testing
- Neuropsychological Testing
- Neurostimulation
- Pain Medication Management
- Parkinson's Disease
- Percutaneous Tibial Nerve Stimulation
- Pulmonary Exercise Testing
- Pulsatile Tinnitus Treatment
- Radiation Therapy
- Seizure Treatment
- Single Photon Emission Computed Tomography
- Somatosensory Evoked Potentials
- Speech Therapy
- Subarachnoid Block
- Swallowing Disorder Treatment
- Tension Headache Treatment
- Transitional Care Planning
- Trigeminal Neuralgia
- Tumor Localization
- Vestibular Testing
Practice locations
Distance from Change LocationEnter your Location
3800 Reservoir Rd NW Pasquerilla Healthcare Center 7th Fl Dept Neurology Washington, DC, 20007
202-444-8525Fax 202-444-2661
Insurance
MedStar Health accepts most major health insurance plans. If you are uncertain as to whether your individual health insurance plan is accepted at MedStar Health, please call your insurance company.
-
List of insurance plans we accept
- Kaiser Permanente Flexible Choice 3-tier POS
- Anthem BCBS Medi Blue Dual Adv
- CIGNA PPO Plus
- Optima Family Care MCO - VA Medicaid MCO
- Aetna Quality Point of Service (POS)
- Jai Medical Systems - Maryland Health Choice
- Johns Hopkins Advantage MD HMO
- CareFirst Blue Card Program
- CareFirst Blue Preferred PPO
- WellPoint Maryland - Maryland Health Choice
- CareFirst Community Health Plan of MD
- Kaiser Permanente Signature - Added Choice
- Aetna VA Exchange
- AmeriHealth Caritas DC Healthcare Alliance
- Anthem BCBS of VA HealthKeepers (HMO)
- Fee-for-Service (FFS) District of Columbia, Maryland and Virginia Medicaid
- MedStar Family Choice - Maryland Health Choice
- Medicare Direct
- UHC Group Medicare Advantage Plans (HMO, POS, PPO)
- IH-Open Network Only Plus
- CareFirst Dual Prime HMO-SNP
- Navigate
- OCI Direct (HMO)
- IH-POS Plus
- Kaiser Permanente Flexible Choice POS Cardiac Global
- Cigna Alliance Medicare (HMO)
- Blue Choice Advantage
- United Healthcare Choice Plus Cardiac Global
- IH-Open POS Plus
- Aetna Advantage 6350PD
- UnitedHealthcare Medicare Adv. Special Needs Plans
- Aetna Premier 200PD
- Fee-for-Service (FFS) District of Columbia, Maryland and Virginia Medicaid
- UnitedHealthcare and AARP Medicare Complete Plans
- CareFirst MedStar Select PPO
- Aetna Managed Choice (POS)
- IH-Open EPO Plus
- HUMANA/Choice Care Medicare Plans (Choice, Gold Choice)
- CIGNA Indemnity
- BCBS Out-of-State Medicare Plans (Blue Advantage)
- Anthem BCBS Medi Blue Plus
- IH-EPO Plus
- TRICARE East Prime
- TRICARE East Select
- Kaiser Maryland Medicaid MCO
- Maryland Physicians Care MCO
- CareFirst Administrators
- Humana Gold Plus HMO
- Great-West Healthcare POS/CIGNA
- Choice POS II
- Aetna Open Choice (PPO)
- United Healthcare Community Plan - VA Medicaid MCO
- Uniformed Services Family Health Plan
- Medicare Advantage - Advantra Value (PPO)
- Aetna Student Health Insurance
- Aetna HMO
- IH-HMO
- Cigna True Choice Plus Medicare (PPO)
- Geisinger Medicare Advantage
- HighMark
- BlueChoice Open Access
- CareFirst Maryland Indemnity or PPO
- Aetna Worker's Compensation Network
- IH-Open POS II
- NYC Medicare Advantage Plus
- Aetna Basic
- United Healthcare Navigate Cardiac Global
- Anthem BCBS of VA HealthKeepers (POS & POS OA)
- UnitedHealthcare Medicare Advantage DSNP District of Columbia
- Amerigroup DC Alliance
- Choice POS II Open Access
- Anthem BCBS of VA HealthKeepers Plus
- CareFirst Blue Choice Opt Out Open Access
- Johns Hopkins Advantage MD PLUS PPO
- IH-POS
- MedStar Family Choice DC Healthcare Alliance
- Kaiser Permanente Select - Added Choice
- Anthem BCBS Medi Blue SNP
- Cigna True Choice Medicare (PPO)
- Humana Medicare Advantage - HMO Open Access
- Aetna Medicare Advantage HMO & PPO Plans
- CareFirst Maryland Point of Service Plan
- Priority Partners - Maryland Health Choice
- Aetna Medicare Advantage PFFS Plan
- IH-Open HMO
- Kaiser Permaenete Signature - Added Choice Cardiac Global
- Choice Fund PPO
- Johns Hopkins Advantage MD PPO
- United Healthcare Choice Plus
- United Healthcare Select HMO - EPO/NPP
- Aetna Signature Administrator PPO/TPA
- M.D. IPA (HMO)
- United Healthcare Choice
- HumanaChoice Honor's plan PPO
- Aetna Traditional Choice (PPO)
- Alterwood Advanatge HMO & DSNP Plans
- UHC Passport
- Mamsi Life & Health (Indem./PPO)
- IH-Open HMO Option
- Private Fee-for-Service Plans (PFFS)
- Mamsi Life & Health (Indem./PPO) Cardiac Global
- Amerigroup DC Healthy Families
- AmeriHealth Caritas DC Healthy Families
- CareFirst Federal Employee Program (Std. & Basic PPO)
- IH-PPO
- Cigna TotalCare (HMO D-SNP)
- Lasso Healthcare - Medicare Medical Savings Account
- CareFirst MedStar PPO
- CIGNA Connect EPO
- CIGNA HMO Open Access
- TRICARE for Life East
- United HealthCare Community Plan - Maryland Health Choice Program
- CareFirst NASCO
- Health Services for Children with Special Needs
- CareFirst (NCA) Indemnity
- Cigna Achieve Medicare (HMO C-SNP)
- Core Essential (HMO)
- Optimum Choice & Optimum Choice Preferred (POS) Cardiac Global
- CIGNA PPO
- Network OA
- United Healthcare Choice Cardiac Global
- Aetna Elect Choice/ Open Access (POS)
- CareFirst FEP Blue Focus
- Coventry Health Care of Virginia
- Kaiser Permanente Medicare Plus
- Aetna Advantage 5750
- IH-Network Only Plus
- Kaiser Permanente Medicare Advantage Signature and Select
- United Healthcare Options (PPO)
- Options PPO Cardiac Global
- Aetna HMO-Open Access/Select OA/HealthFund/Health Network Option OA
- Cigna Preferred Medicare (HMO)
- Magellan Complete Care of VA - VA Medicaid MCO
- Tricare Reserve Select
- UnitedHealthcare Individual Exchange Plans
- United Healthcare Select Plus (POS)
- CareFirst BlueChoice HMO
- POS OA
- CIGNA POS/Network POS
- Aetna Managed Choice Open Access (POS)
- AMERIVANTAGE/Amerigroup Community Care
- CareFirst BlueCross BlueShield Advantage Core/Enhanced
- CIGNA EPO
- Advantra Platinum (PPO)
- Kaiser Permanente HMO Plus and DHMO Plus Member
- Mamsi Life & Health (Indem./PPO)
- United Medicare Private Fee-for-Service (PFFS) plans
- Veterans Affairs Community Care Network
- Employee Health Plan
- United Student Resources
- M.D. IPA Preferred (POS)
- Police and Fire Clinic
- Optimum Choice
- Beech Street PPO
- CareFirst Group Medicare Advantage prescription drug benefit (PPO)
- United Healthcare Select HMO-EPO/NPP Cardiac Global
- CIGNA SureFit (HMO)
- First Health PPO
- Private Health Care Systems (PPO)
- UnitedHealthcare Individual Exchange Plans
- Aetna Classic 5000PD
- IH-Indemnity
- Aetna Elect Choice/ EPO (Aetna Health Fund)
- CareFirst Group Medicare Advantage
- MultiPlan, Inc
- Choice Care Network/HUMANA (PPO)
- Sentara Health
- HumanaChoice PPO
- CareFirst Blue Choice Opt Out Plus Open Access (POS)
- BCBS of Michigan (BCN Advantage,Security Blue, Freedom, Medicare PLUS Blue Group PPO)
- Humana Medicare Advantage - PPO
- Anthem Federal Employee Program Standard
- First Health PPO
- Erickson Advantage Plans
- Medicare FFS
- MedStar Family Choice - Maryland Health Choice
- Coventry of Delaware HMO/PPO
- MedStar Family Choice DC Healthcare Alliance
- Anthem BCBS of VA Key Care POS/PPO/Indemnity
- Coventry Health Care National Network PPO
- Healthy Blue (HMO, POS)
- Aetna Advantage 6350
- OA Plus
- Kaiser Permanente Select Cardiac Global
- Anthem Federal Employee Program Basic
- Kaiser Permanente Select
- Select HMO/HealthFund/Health Network
- CareFirst EPO
- Choice POS
- TriWest Healthcare Alliance
- Aetna Classic 3500
- Optimum Choice Preferred (POS)
- HealthyBlue PPO
- Kaiser Permanente Signature
- MD IPA (HMO) & MD IPA Preferred Cardiac Global
- Aetna Better Health of MD
- CIGNA HMO & Network (HMO)
- DC/MD SHOP QHP Small Business Plans
- Aetna Better Health of VA
- Aetna Classic 5000
- MedStar Family Choice DC Healthy Families
Education
Board Certification: American Board of Psychiatry and Neurology, Psychiatry and Neurology
Fellowship: Hospital of the University of Pennsylvania (1995)
Residency: Hospital of the University of Pennsylvania (1992)
Internship: University of Pennsylvania School of Medicine GME (1989)
Medical School: Emory University School of Medicine (1988)
Awards
- Paul Beeson Career Development Award in Aging Research American Federation for Aging Research, Postdoctoral Research Fellowship for Physician-Scientists Howard Hughes Medical Institute Alzheimer's Association Honoree, Washington Monuments, National Capital Area Chapter, Alzheimer's Association
Hospital affiliations
News and publications
- Diaz-Asper C, Chandler C, Turner RS, Reynolds B, Elvevåg B: Increasing access to cognitive screening in the elderly: applying natural language processing methods to speech collected over the telephone. Cortex. 2022 Nov;156:26-38. doi: 10.1016/j.cortex.2022.08.005. Epub 2022 Aug 30. PMID: 36179481
- Greco GA, Rock M, Amontree M, Lanfranco MF, Korthas H, Hong SH, Turner RS, Rebeck GW, Conant K: CCR5 deficiency normalizes TIMP levels, working memory, and gamma oscillation power in APOE4 targeted replacement mice. Neurobiol Dis. 2023 Apr;179:106057. doi: 10.1016/j.nbd.2023.106057. Epub 2023 Mar 5. PMID 36878326
- Stevenson M, Varghese R, Hebron ML, Liu X, Ratliff N, Smith A, Turner RS, Moussa C: Inhibition of discoidin domain receptor (DDR)-1 with nilotinib induces autophagy and reduces inflammation and vascular fibrosis in Alzheimer’s disease. J Neuroinflammation. 2023 May 16;20(1):116. doi: 10.1186/s12974-023-02802-0. PMID: 37194065
- Bushnell J, Hammers DB, Aisen P, Dage JL, Eloyan A, Foroud T, Grinberg LT, Iaccarino L, Jack CR Jr, Kirby K, Kramer J, Koeppe R, Kukull WA, La Joie R, Mundada NS, Murray ME, Nudelman K, Rumbaugh M, Soleimani-Meigooni DN, Toga A, Touroutoglou A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha S, Turner RS, Wingo TS, Wolk DA, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova LG, Clark DG; LEADS Consortium. Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's disease. Alzheimers Dement. 2023 Aug 31. doi: 10.1002/alz.13434. Online ahead of print. PMID: 37653686
- Cho H, Mundada NS, Apostolova LG, Carrillo MC, Shankar R, Amuiri AN, Zeltzer E, Windon CC, Soleimani-Meigooni DN, Tanner JA, Heath CL, Lesman-Segev OH, Aisen P, Eloyan A, Lee HS, Hammers DB, Kirby K, Dage JL, Fagan A, Foroud T, Grinberg LT, Jack Jr. CR, Kramer J, Kukull WA, Murray ME, Nudelman K, Toga A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha S, Turner RS, Wingo TS, Wolk DA, Koeppe R, Iaccarino L, Dickerson BC, La Joie R, Rabinovici G. Amyloid and tau-PET in early-onset AD: baseline data from the Longitudinal Early-onset Alzheimer’s Disease Study (LEADS). Alzheimers Dement. 2023 Sep 10. doi: 10.1002/alz.13453. Online ahead of print. PMID: 3769010
- Dage JL, Eloyan A, Thangarajah M, Hammers DB, Fagan AM, Gray JD, Schindler SE, Snoddy C, Nudelman K, Faber KM, Foroud T, Aisen P, Ghetti B, Griffin P, Grinberg LT, Jack Jr CR, Kirby K, Kramer J, Koeppe R, Kukull WA, Murray ME, Rumbaugh M, Toga A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha S, Turner RS, Wingo TS, Wolk DA, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova L: Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer’s Disease Study. Alzheimers Dement. 2023 Jul 25. doi: 10.1002/alz.13399. Online ahead of print. PMID: 37491668
- Eloyan A, An N, Thangarajah M, Dage JL, Fagan AM, Foroud T, Aisen P, Ghetti B, Griffin P, Grinberg LT, Jack Jr CR, Kirby K, Kramer J, Koeppe R, Kukull WA, Murray ME, Rumbaugh M, Toga A, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha S, Turner RS, Wingo TS, Wolk DA, Beckett L, Gao S, Carrillo MC, Rabinovici G, Apostolova LG, Dickerson B, Vemuri P: White matter hyperintensities are higher among early-onset Alzheimer’s disease participants than their cognitively normal and early-onset nonAD peers: LEADS Study. Alzheimers Dement. 2023 Jul 25. doi: 10.1002/alz.13402. Online ahead of print. PMID: 37491599
- Hammers DB, Nemes S, Diedrich T, Eloyan A, Kirby K, Aisen P, Kramer J, Nudelman K, Foroud T, Rumbaugh M, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu JC, Mendez MF, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha SJ, Turner RS, Weintraub S, Wingo TS, Wolk DA, Wong B, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova LG; LEADS Consortium. Learning slopes in early-onset Alzheimer’s disease. Alzheimers Dement 2023 May 27. doi: 10.1002/alz.13159. Online ahead of print. PMID: 37243937
- Hammers DB, Eloyan A, Taurone A, Thangarajah M, Beckett L, Gao S, Kirby K, Aisen P, Dage JL, Foroud T, Griffin P, Grinberg LT, Jack CR Jr, Kramer J, Koeppe R, Kukull WA, Mundada NS, La Joie R, Soleimani-Meigooni DN, Iaccarino L, Murray ME, Nudelman K, Polsinelli AJ, Rumbaugh M, Toga A, Touroutoglou A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez MF, Womack K, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha SJ, Turner RS, Wingo TS, Wolk DA, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova LG; LEADS Consortium.Profiling baseline performance on the longitudinal early-onset Alzheimer’s disease study (LEADS) cohort near the midpoint of data collection. Alzheimers Dement 2023 May 31. doi: 10.1002/alz.13160. Online ahead of print. PMID: 37256497
- Nemes S, Logan PE, Manchella M, Mundada NS, La Joie R, Polsinelli AJ, Hammers DB, Koeppe RA, Foroud TM, Nudelman KN, Eloyan A, Iaccarino L, Dorsant-Ardon V, Taurone A, Thangarajah M, Aisen P, Grinberg LT, Jack Jr. CR, Kramer J, Kukull WA, murray ME, Rumbagh M, Toga A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha SJ, Turner RS, Wingo TS, Wolk DA, Rabinovici GD, Carrillo MC, Dickerson BC, Apostolova LG. Sex and APOE-e4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer’s disease. Alzheimers Dement. 2023 Jul 26. doi: 10.1002/alz.13403. Online ahead of print. PMID: 37496307
- Nudelman KNH, Jackson T, Rumbaugh M, Eloyan A, Abreu M, Dage JL, Snoddy C, Faber KM, Foroud T, Hammers DB, DIAN/DIAN-TU Clinical/Genetics Committee, Taurone A, Aisen P, Grinberg LT, Jack Jr CR, Kramer J, Koeppe R, Kukull WA, Murray ME, Toga A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha S, Turner RS, Wingo TS, Wolk DA, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova L. Pathogenic variants in the longitudinal early-onset Alzheimer’s disease study cohort. Alzheimers Dementia, 2023 Oct 6. doi: 10.1002/alz.13482. Online ahead of print. PMID: 37801072
- Polsinelli AJ, Wonderlin RJ, Hammers DB, Garcia AP, Eloyan A, Taurone A, Thangarajah M, Beckett L, Gao S, Wang S, Kirby K, Logan PE, Aisen P, Dage JL, Foroud T, Griffin P, Iaccarino L, Kramer JH, Koeppe R, Kukull WA, La Joie R, Mundada NS, Murray ME, Nudelman K, Soleimani-Meigooni DN, Rumbaugh M, Toga AW, Touroutoglou A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez MF, Womack K, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha SJ, Turner RS, Wingo TS, Wolk DA, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova LG, LEADS Consortium. Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS) Cohort. Alzheimers Dement 2023 Jun 9. doi: 10.1002/alz.13344. Online ahead of print. PMID: 37296082
- Touroutoglou A, Katsumi Y, Brickhouse M, Aisen P, Beckett L, Dage JL, Eloyan A, Fagan A, Foroud T, Ghetti B, Griffin P, Grinberg LT, Jack Jr. CR, Kramer J, Koeppe R, Kukull WA, Murray ME, Nudelman K, Posinelli A, Rumbaugh M, Toga A, Vemuri P, Altri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha S, Turner RS, Wingo TS, Wolk DA, Carrillo MC, Rabinovici GD, Apostolova LG, Dickerson BC. The sporadic early-onset Alzheimer’s disease signature of atrophy: Preliminary findings from the Longitudinal Early-onset Alzheimer’s Disease Study (LEADS) cohort. Alzheimers Dement 2023 Oct 18. doi: 10.1002/alz.13466. Online ahead of print. PMID: 37850549
- Clark DG, Bushnell J, Hammers DB, Aisen P, Dage J, Eloyan A, Foroud T, Grinberg L, Iaccarino L, Jack C, Kirby K, Kramer J, Koeppe R, Kukull W, La Joie R, Mundada N, Murray M, Nudelman K, Rumbaugh M, Soleimani-Meigooni D, Toga A, Touroutoglou A, Vemuri P, Atri A, Day G, Duara R, Graff-Radford N, Honig L, Jones D, Masdeu J, Mendez M, Musiek E, Onyike C, Riddle M, Rogalski E, Salloway S, Sha S, Turner RS, Wingo T, Wolk D, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova LG. Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer’s disease. Alzheimers Dement, in press, 2023
- Monane M, Johnson KG, Snider BJ, Turner RS, Drake JD, Maraganore DM, Bicksel JL, Jacobs DH, Ortega JL, Henderson J, Jiang Y, Huang S, Coppinger J, Fogelman I, West T, Braunstein JB: A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairment. Ann Clin Transl Neurol. 2023 Oct;10(10):1738-1748. doi: 10.1002/acn3.51863. Epub 2023 Aug 7. PMID: 37550958
- Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler-Klein M, Fox NC, Cumming JL, Fontoura P, Doody RS: Two phase 3 trials of gantenerumab in early Alzheimer’s disease. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. PMID: 37966285
- Riviere M-E, Langbaum JB, Turner RS, Rinne JO, Sui Y, Cazorla P, Ricart J, Meneses K, Caputo A, Tariot PN, Reiman EM, Graf A: Active immunotherapy CAD106 in Alzheimer’s disease: effect on amyloid deposition in cognitively unimpaired ApoE4 homozygotes. Alzheimers Dement. 2023 Dec 25. doi: 10.1002/alz.13532. Online ahead of print. PMID: 38145469
- Chandler C, Diaz-Asper C, Turner RS, Reynolds B, Elvevåg B: An explainable learning model of cognitive decline derived from acoustic and linguistic speech features. Alzheimers Dement (Amst). 2023 Dec 27;15(4):e12516. doi: 10.1002/dad2.12516. eCollection 2023 Oct-Dec. PMID: 38155915
- Amontree M, Nelson M, Stefansson L, Pak D, Maguire-Zeiss K, Turner RS, Conant K. Resveratrol differentially affects MMP release from neurons and glia: Implications for therapeutic efficacy. J Neurochem. 2024 Jan 1. doi: 10.1111/jnc.16031. Online ahead of print. PMID: 38163875
- Feldman HH, Messer K, Qui Y, Sabbagh M, Galasko D, Turner RS, Lopez O, Smith A, Durant J, Lupo J-L, Revta C, Balasubramanian A, Kuehn-Wache K, Wassmann T, Schell-Mader S, Jacobs DM, Salmon DP, Leger G, Weber F, for the ADCS VIVA-MIND Study Group. Varoglutamstat: Inhibiting glutaminyl cyclase as a novel target of therapy in early Alzheimer’s disease. J Alzheimers Disease, in press, 2024